Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 153

Results For "Men"

10135 News Found

BPL MedTech unveils new ICU ventilator BPL Vent 300
Medical Device | June 04, 2026

BPL MedTech unveils new ICU ventilator BPL Vent 300

The ventilator features a high-performance turbine capable of delivering up to 240 L/min peak flow


ResMed acquires Noctrix Health for $340 million
Medical Device | June 04, 2026

ResMed acquires Noctrix Health for $340 million

Following the completion of the acquisition on June 3, Noctrix’s flagship product, Nidra will become part of ResMed’s broader sleep medicine portfolio


Novo Nordisk launches Wegovy pill in UAE in first global rollout outside US
News | June 04, 2026

Novo Nordisk launches Wegovy pill in UAE in first global rollout outside US

The move signals a major expansion in access to next-generation weight-loss therapies


Alembic appoints Ramesh Juneja as Executive Vice President – Human Health for India business
People | June 04, 2026

Alembic appoints Ramesh Juneja as Executive Vice President – Human Health for India business

Juneja brings more than three decades of experience in pharmaceutical sales and marketing


India’s medical devices sector is poised for a pharma-like transformation:  Pranav Sharma, SBU Head - Advanced Surgery, Healthium MedTech
interviews | June 03, 2026

India’s medical devices sector is poised for a pharma-like transformation: Pranav Sharma, SBU Head - Advanced Surgery, Healthium MedTech

The industry is expected to grow significantly over the next few years as healthcare accessibility improves and insurance penetration increases


Alkem launches single-shot Semaglutide pre-filled syringes at Rs. 350
News | June 03, 2026

Alkem launches single-shot Semaglutide pre-filled syringes at Rs. 350

DCGI-approved semaglutide syringes for diabetes and obesity expand treatment choices and improve affordability


Servier to acquire Edgewise muscular dystrophy business in $2.65 billion deal
News | June 03, 2026

Servier to acquire Edgewise muscular dystrophy business in $2.65 billion deal

The transaction includes an upfront payment of $1.55 billion, along with up to $1.1 billion in regulatory and commercial milestone payments


Omnix Medical doses first patients in phase II trial of antimicrobial lead compound OMN6
News | June 03, 2026

Omnix Medical doses first patients in phase II trial of antimicrobial lead compound OMN6

First-in-class treatment of life-threatening, drug-resistant Acinetobacter baumannii infections advancing toward Phase II clinical proof-of-concept


Intracin Pharma secures APVMA nod to supply veterinary medicines in Australia
News | June 03, 2026

Intracin Pharma secures APVMA nod to supply veterinary medicines in Australia

Regulatory clearance strengthens company’s global footprint and expands access to the Australian animal healthcare market


Abbott highlights prognostic value of MRD testing for breast cancer recurrence
Clinical Trials | June 03, 2026

Abbott highlights prognostic value of MRD testing for breast cancer recurrence

New PARTNER trial sub-study data show that post-operative ctDNA detection using tumour-informed MRD assays can accurately predict distant recurrence risk in triple-negative breast cancer patients